Korean Firms Repurpose FDA-approved Drug for Rheumatoid Arthritis Treatment
The BioSpectrum website reported that Standigm Inc, an artificial intelligence-based drug discovery company and SK Chemicals Co, Ltd, a life science and green chemicals company have announced that they have successfully found a new rheumatoid arthritis indication for an FDA-approved drug and have filed a patent. This is the first successful result of their open innovation partnership, formed in July 2019. Jeonghoon Kim, Director of the R&D Center, SK Chemicals, said, “The recent findings result from our successful open innovation partnership, which combines Standigm’s advanced AI platform technology and SK Chemicals’ deep expertise in drug discovery and development.”
Click here to read the full article.